Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 623 is a human protein encoded by the ZNF623 gene, also known as KIAA0628. It contains zinc finger domains and is predicted to act as a DNA-binding transcription factor, likely involved in the regulation of transcription via interactions with specific DNA sequences. No direct evidence identifies it as a therapeutic target, nor are there known drugs or disease-linked mechanisms documented for this protein to date. Expression of ZNF623 has been profiled in multiple normal and cancer tissues, suggesting a potential role in cell biology and cancer, though no established disease association or biomarker use is reported[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 623 (ZNF623).